Avalo Therapeutics Balance Sheet (2014-2026) | AVTX

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
0.16M0.05M38.47M0.01M0.05M0.01M16.69M6.31M10.18M7.42M0.00M81.86M134.55M0.06M0.02M0.09M15.86M0.15M85.38M
Short-term Investments (Quarter)
70.97M84.65M82.48M57.01M314.89M
Cash & Current Investments (Quarter)
0.16M0.05M38.47M0.01M0.05M0.01M16.69M6.31M10.18M7.42M0.00M81.86M134.55M0.06M70.99M84.74M98.34M57.15M400.28M
Receivables - Net (Quarter)
1.44M1.06M0.94M0.90M0.80M0.04M
Receivables - Other (Quarter)
2.48M1.26M-2.29M1.31M1.31M0.60M-1.06M0.01M1.54M-1.40M-0.10M-0.10M1.00M-0.39M
Receivables (Quarter)
3.91M2.32M-1.36M2.21M2.11M0.60M0.04M
Raw Materials (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)
0.02M0.04M0.03M0.02M0.02M0.02M0.02M0.02M
Prepaid Assets (Quarter)
1.41M2.37M2.68M1.89M1.12M1.29M1.63M1.14M0.94M0.50M0.10M0.10M0.90M4.33M1.83M1.90M2.14M6.91M6.68M7.61M
Current Assets (Quarter)
77.01M61.84M43.66M15.02M19.45M16.42M19.25M7.52M12.66M8.39M111.21M95.89M86.15M138.89M126.94M115.19M113.85M105.29M88.83M407.93M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
1.41M2.69M2.60M2.57M2.51M2.41M2.44M2.18M2.07M1.97M1.88M1.78M1.67M1.21M0.95M0.69M0.54M0.46M0.38M0.29M
Long-Term Investments (Quarter)
71.88M
Goodwill (Quarter)
10.50M
Intangibles (Quarter)
0.30M0.04M
Goodwill & Intangibles (Quarter)
10.50M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)
0.18M
Non-Current Assets (Quarter)
82.85M
Assets (Quarter)
490.78M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
3.35M
Notes Payables (Quarter)
2.56M5.93M9.30M14.12M0.36M0.36M0.37M
Payables (Quarter)
3.35M
Accumulated Expenses (Quarter)
17.78M
Other Accumulated Expenses (Quarter)
0.65M0.38M0.44M0.28M0.40M0.51M0.45M0.61M0.21M0.24M0.33M0.33M0.33M0.33M0.33M0.33M
Short term Debt (Quarter)
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)
0.44M0.09M0.11M
Total Current Liabilities (Quarter)
21.13M
Non-Current Liabilities
Non-Current Debt (Quarter)
32.48M32.83M33.18M18.71M16.50M13.49M10.47M
Preferred Stock Liabilities (Quarter)
11.46M11.46M1.66M
Liabilities from Discontinued Operations (Quarter)
0.01M
Non-Current Deferred Tax Liability (Quarter)
0.46M
Operating Leases (Quarter)
Other Non-Current Liabilities (Quarter)
17.52M18.53M
Total Non-Current Liabilities (Quarter)
23.59M
Total Liabilities (Quarter)
42.12M
Shareholder's Equity
Total Debt (Quarter)
32.48M32.83M33.18M18.71M16.50M13.49M10.47M
Common Equity (Quarter)
448.66M
Liabilities and Shareholders Equity (Quarter)
490.78M
Retained Earnings (Quarter)
953.70M
Preferred Shares (Quarter)
Treasury Shares (Quarter)
0.18M